Results 111 to 120 of about 14,207 (206)

Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations. [PDF]

Int J Pharm, 2023
Howe C, Momin MAM, Aladwani G, Strickler S, Hindle M, Longest W.   +5 more
europepmc   +1 more source

Allyl isothiocyanate dry powder inhaler based on cyclodextrin-metal organic frameworks for pulmonary delivery. [PDF]

iScience, 2023
Sun N, Zhang M, Zhu W, Song P, Dai T, Huang P, Han Z, Wang D.   +7 more
europepmc   +1 more source

Switching to the Dry Powder Inhaler: Disease Control with a Lower Carbon Footprint. [PDF]

Pulm Ther
Janson C, Hisinger-Mölkänen H, Tamasi L, Vartiainen V, Lehtimäki L.   +4 more
europepmc   +1 more source

Patient Perceptions of Switching to a Generic Dry Powder Inhaler - Increased Understanding Through Journey Mapping. [PDF]

Int J Chron Obstruct Pulmon Dis, 2022
Ray SE, Boudewyns V, Davis C, Tzeng JP, Srivastava I, Oguntimein O, Conti DS, Feibus KB.   +7 more
europepmc   +1 more source

In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler. [PDF]

J Aerosol Med Pulm Drug Deliv, 2023
Hamilton M, Anderson M, Dhand R, Patmore O, Prime D, Taylor E.   +5 more
europepmc   +1 more source

A CFD-DEM investigation of powder transport and aerosolization in ELLIPTA® dry powder inhaler. [PDF]

Powder Technol, 2022
Sulaiman M, Liu X, Sundaresan S.
europepmc   +1 more source

Hydroxypropyl Methylcellulose Capsules Enhance Aerodynamic Performance of Carrier-Based Dry Powder Inhaler Formulations: A Comprehensive Evaluation of Capsule Material Effects. [PDF]

Pharmaceutics
Dumont C, Picco S, Noriega-Fernandes B, Verlhac P, Elena Cortez A, Boulet C, Gallagher M, Bock C, Jannin V.   +8 more
europepmc   +1 more source

Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics. [PDF]

Pharm Res, 2023
Drescher SK, Jiao Y, Chen MJ, Kurumaddali A, Shao J, Amini E, Hochhaus G, Bulitta JB.   +7 more
europepmc   +1 more source

Switching to the Dry-Powder Inhaler Easyhaler^®: A Narrative Review of the Evidence. [PDF]

Pulm Ther, 2021
Lavorini F, Chudek J, Gálffy G, Pallarés-Sanmartin A, Pelkonen AS, Rytilä P, Syk J, Szilasi M, Tamási L, Xanthopoulos A, Haahtela T.   +10 more
europepmc   +1 more source

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis. [PDF]

Asian J Pharm Sci, 2022
Lu P, Li J, Liu C, Yang J, Peng H, Xue Z, Liu Z.   +6 more
europepmc   +1 more source